WASHINGTON — The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions designed to block access to gender-affirming care for minors, building on broader Trump administration restrictions targeting transgender Americans.
The sweeping proposals — the most significant moves this administration has taken so far to restrict the use of puberty blockers, hormone therapy and surgical interventions for transgender children — include cutting off federal Medicaid and Medicare funding from hospitals that provide gender-affirming care to children and prohibiting federal Medicaid dollars from being used to fund such procedures.
''This is not medicine, it is malpractice,'' Health Secretary Robert F. Kennedy Jr. said of gender-affirming procedures in a news conference on Thursday. ''Sex-rejecting procedures rob children of their futures.''
Thursday's announcements would imperil access in nearly two dozen states where drug treatments and surgical procedures remain legal and covered by Medicaid, which is funded by federal and state dollars.
The proposals run counter to the recommendations of major U.S. medical societies. And advocates for transgender children strongly refuted the administration's claims about gender-affirming care, saying Thursday's moves would put lives at risk.
''The multitude of efforts we are seeing from federal legislators to strip transgender and nonbinary youth of the health care they need is deeply troubling,'' said Rodrigo Heng-Lehtinen, of The Trevor Project, a nonprofit suicide prevention organization for LBGTQ+ youth.
Proposed rules would threaten youth gender-affirming care in states where it remains legal
Medicaid programs in slightly less than half of states currently cover gender-affirming care. At least 27 states have adopted laws restricting or banning the care. The Supreme Court's recent decision upholding Tennessee's ban means most other state laws are likely to remain in place.